Search for: "Impax Laboratories, Inc" Results 21 - 40 of 78
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Feb 2013, 4:43 pm by Mandour & Associates
Watson Pharmaceuticals Inc. and Impax Laboratories Inc. both sent letters to Purdue in December, informing the company of their plans to make a generic form of the drug. [read post]
9 Jan 2017, 9:36 am by Lawrence B. Ebert
Ct. 831 (2015).But see also Teva loses on 40mg Copaxone (for MS) at PTAB Separately, from NASDAQ.com on 9 January 2017:Impax Laboratories, Inc. [read post]
21 Jan 2013, 7:27 am by Lawrence B. Ebert
Food and Drug Administration said Wednesday the product, Budeprion XL 300 milligrams, which is manufactured by Impax Laboratories Inc. and marketed by Teva Pharmaceuticals USA Inc., "is not therapeutically equivalent to Wellbutrin XL 300 mg" or the extended-release version of Wellbutrin.In a post titled A Drug Recall That Should Frighten Us All About The FDA The People’s Pharmacy, a well-known syndicated radio and newspaper columnist husband and wife team,… [read post]
24 Sep 2015, 8:43 am by Steve Brachmann
On August 10th, the rights to sell Daraprim were bought from Impax Laboratories Inc. [read post]
21 Aug 2008, 4:57 am
., Apotex, Inc., and Torpharm Inc. on the one hand and Impax Laboratories on the other, were found to infringe the patents in suit, and... [read post]
9 Oct 2009, 9:11 am
Impax Laboratories (patent infringement) 9/18: Ricoh Company Ltd. and Ricoh Americas Corporation v. [read post]
17 Aug 2009, 8:01 am
On June 22, 2007, the Company received a civil investigative demand requesting that it provides information to the FTC relating to its settlement with Barr and its earlier settlement with Impax Laboratories, Inc. [read post]
17 Aug 2009, 8:01 am
On June 22, 2007, the Company received a civil investigative demand requesting that it provides information to the FTC relating to its settlement with Barr and its earlier settlement with Impax Laboratories, Inc. [read post]
2 Dec 2009, 11:05 am by dbmadmin
Under the order’s terms, Watson will sell its generic cabergoline product to Impax Laboratories Inc. and Arrow will spin off its subsidiary, Resolution Chemicals, which is currently developing generic dronabinol, to a new entity, Reso Holdings, within 10 days of the acquisition. [read post]
18 Apr 2016, 12:49 pm by Gene Quinn
The FTC’s complaint alleges that Endo engaged in a pay for delay scheme by paying the first generic companies that filed for FDA approval – Impax Laboratories, Inc. and Watson Laboratories, Inc. [read post]
27 Oct 2021, 5:15 am by Dennis Crouch
(functional trade dress); Impax Laboratories, Inc. v. [read post]